Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
Sem A O F RikkenWillem L BorAbi SelvarajahKai L ZhengAmy P HackC Michael GibsonChristopher B GrangerOhad S BenturBarry S CollerArnoud W J van 't HofJurriën M Ten BergPublished in: American heart journal (2023)
This post hoc analysis found that higher doses of zalunfiban administered in the cardiac catheterization lab prior to vascular access were associated with greater coronary and myocardial perfusion, and lower thrombus burden at initial angiogram in patients with STEMI undergoing primary percutaneous coronary intervention.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- blood flow
- st segment elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- antiplatelet therapy
- acute coronary syndrome
- coronary artery
- randomized controlled trial
- coronary artery bypass
- left ventricular
- aortic valve
- aortic stenosis